medicinal cannabis
medicinal cannabis · page 3
- CBD Market
2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models
Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities and challenges for the European cannabis industry in 2022?
- CBD Market
A Ground-Breaking Year For European Cannabis Mapped Out In BusinessCann’s 2021 Top 10
THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into the post-prohibition era.
- Pharmaceutical
German Pharmaceutical Firm Enters Cannabis Space With Purchase Of Canopy Growth European Asset
FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group.
- News
After Securing Cultivation Licence Guernsey-Based 4C Labs Will Open UK Medical Cannabis Tele-Clinics
4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch virtual health clinics in the coming year.
- Medical
UK Government Fails To Back New Measures To Boost Medical Cannabis Access
CONSERVATIVE MPs have blocked efforts to boost UK medical cannabis access with the Government saying the existing legislation is sufficient.
- Press releases
First Cancer Patients Treated With Apollon Formularies Products At The International Cancer and Chronic Pain Institute
Apollon Formularies Plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international medical cannabis pharmaceutical company trading on Aquis Stock Exchange, is pleased to announce that the International Cancer and Chronic Pain Institute is now officially open and has welcomed the first cancer patients to be treated with Apollon’s proprietary medical cannabis products.
- Pharmaceutical
Work To Start On UK Mainland’s First Commercial Cannabis Cultivation Facility For Over 20 Years
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.
- Medical
Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny
ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and civil society groups are backing for calls for greater transparency over emerging new cannabis guidelines.
- Markets & Stocks
MGC Pharmaceuticals Tells Shareholders Pending Deal Could ‘Transform Finances Overnight’
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away the best financial performance of the company’ in the coming months.
- News
French Biotech Start-up Secures Country’s First Medical Cannabis Research Licence
Biotech start-up Overseed has been awarded the first licence for agronomic and genetic research on cannabis in France by the National Agency for the Safety of Medicines and Health Products (ANSM).
- News
Former Prime Minister’s Cannabis Company Delivers 170% Sales Boost
INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter.
- Cultivation
Guernsey Issues Its First Medical Cannabis Cultivation Licence To 4C Labs With More Set To Follow
4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking a major milestone for the Channel Islands’ cannabis industry.
